Skip to main content
Log in

Radiotherapy for benign calcaneodynia

Long-term results of the Erlangen Dose Optimization (EDO) trial

Strahlentherapie bei Calcaneodynie

Langzeitergebnisse der Erlanger Dosisoptimierungsstudie (EDO)

  • Original article
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

Abstract

Background and purpose

The goal of this work was to evaluate the long-term efficacy of two dose-fractionation schedules for radiotherapy of calcaneodynia.

Patients and methods

Between February 2006 and February 2010, 457 evaluable patients were recruited for this prospective trial. All patients received orthovoltage radiotherapy. One course consisted of 6 fractions/3 weeks. In case of insufficient remission of pain after 6 weeks a second series was performed. Patients were randomly assigned to receive either single doses of 0.5 or 1.0 Gy. Endpoint was pain reduction. Pain was measured before, right after (early response), 6 weeks (delayed response), and approximately 2.5 years after radiotherapy (long-term response) with a questionnaire-based visual analogue scale (VAS) and a comprehensive pain score (CPS).

Results

The median follow-up was 32 months (range 9–57 months). The overall early, delayed, and long-term response rates for all patients were 87, 88, and 95 %. The mean VAS values before treatment, for early, delayed, and long-term response for the 0.5 and 1.0 Gy groups were 65.5 ± 22.1 and 64.0 ± 20.5 (p = 0.19), 34.8 ± 24.7 and 39.0 ± 26.3 (p = 0.12), 25.1 ± 26.8 and 28.9 ± 26.8 (p = 0.16), and 16.3 ± 24.3 and 14.1 ± 19.7 (p = 0.68). The mean CPS values before treatment, for early, delayed, and log-term response were 10.1 ± 2.7 and 10.0 ± 3.0 (p = 0.78), 5.6 ± 3.7 and 6.0 ± 3.9 (p = 0.34), 4.0 ± 4.1 and 4.3 ± 3.6 (p = 0.26), and 2.1 ± 3.3 and 2.3 ± 3.2 (p = 0.34), respectively. No significant differences in long-term response quality between the two arms were found (p = 0.50).

Conclusion

Radiotherapy is a very effective treatment for the management of benign calcaneodynia. For radiation protection reasons, the dose for a RT series should not exceed 3.0 Gy.

Zusammenfassung

Hintergrund und Ziel

Untersuchung der Langzeiteffektivität zweier Dosisfraktionierungskonzepte bei der Strahlentherapie von Patienten mit Calcaneodynie.

Patienten und Methoden

Zwischen 2006 und 2010 wurden 457 auswertbare Patienten in diese prospektive und randomisierte Phase-IV-Studie eingeschlossen. Alle Patienten erhielten die Bestrahlung in Orthovolt-Technik. Eine Bestrahlungsserie bestand aus 6 Fraktionen/3 Wochen. Bei ungenügendem Ansprechen der Schmerzsymptomatik nach 6 Wochen wurde eine zweite Bestrahlungsserie durchgeführt. Die Patienten wurden auf die beiden Studienarme randomisiert und erhielten je nach Ergebnis Einzeldosen von 0,5 bzw. 1,0 Gy. Der Endpunkt der vorliegenden Analyse war die Schmerzreduktion. Die Schmerzintensität wurde vor, unmittelbar nach ("early response"), 6 Wochen nach ("delayed response") sowie etwa 2,5 Jahre nach der Strahlentherapie ("long-term response") mittels visueller Analogskala (VAS) und einem umfassenden Schmerzscore (CPS) gemessen.

Ergebnisse

Die mediane Nachbeobachtungszeit betrug 32 Monate (Spanne 9–57 Monate). Die Raten für das frühe, verzögerte und Langzeitansprechen aller Patienten betrugen 87, 88 und 95 %. Die mittleren VAS-Werte vor Behandlung, für das frühe, verzögerte und Langzeitansprechen waren für die 0,5- und 1,0-Gy-Gruppe 65,5 ± 22,1 und 64,0 ± 20,5 (p = 0,19), 34,8 ± 24,7 und 39,0 ± 26,3 (p = 0,12), 25,1 ± 26,8 und 28,9 ± 26,8 (p = 0,16) sowie 16,3 ± 24,3 und 14,1 ± 19,7 (p = 0,68). Die entsprechenden mittleren CPS-Werte betrugen 10,1 ± 2,7 und 10,0 ± 3,0 (p = 0,78), 5,6 ± 3,7 und 6,0 ± 3,9 (p = 0,34), 4,0 ± 4,1 und 4,3 ± 3,6 (p = 0,26) sowie 2,1 ± 3,3 und 2,3 ± 3,2 (p = 0,34). Zwischen den beiden Studienarmen konnten keinerlei statistisch signifikante Unterschiede in der Qualität des Langzeitansprechens festgestellt werden (p = 0,50).

Schlussfolgerung

Die Strahlentherapie ist langfristig eine sehr effektive Maßnahme zur Behandlung der Calcaneodynie. Aus Strahlenschutzgründen sollte eine Gesamtdosis von 3 Gy pro Bestrahlungsserie nicht überschritten werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cole C, Seto C, Gazewood J (2005) Plantar fasciitis: evidence-based review of diagnosis and therapy. Am Fam Physician 72:2237–2242

    PubMed  Google Scholar 

  2. Barrett SJ, O’Malley R (1999) Plantar fasciitis and other causes of heel pain. Am Fam Physician 59:2200–2206

    CAS  PubMed  Google Scholar 

  3. Toomey EP (2009) Plantar heel pain. Foot Ankle Clin 14:229–245

    Article  PubMed  Google Scholar 

  4. Young CC, Rutherford DS, Niedfeldt MW (2001) Treatment of plantar fasciitis. Am Fam Physician 63:467–474, 477–468

    Google Scholar 

  5. Ott OJ, Hertel S, Gaipl US et al (2012) Benign painful shoulder syndrome: initial results of a single-center prospective randomized radiotherapy dose-optimization trial. Strahlenther Onkol 188:1108–1113

    Article  CAS  PubMed  Google Scholar 

  6. Ott OJ, Hertel S, Gaipl US et al (2012) Benign painful elbow syndrome. First results of a single center prospective randomized radiotherapy dose optimization trial. Strahlenther Onkol 188:873–877

    Article  CAS  PubMed  Google Scholar 

  7. Ott OJ, Jeremias C, Gaipl US et al (2013) Radiotherapy for achillodynia: results of a single-center prospective randomized dose-optimization trial. Strahlenther Onkol 189:142–146

    Article  CAS  PubMed  Google Scholar 

  8. Heyd R, Tselis N, Ackermann H et al (2007) Radiation therapy for painful heel spurs: results of a prospective randomized study. Strahlenther Onkol 183:3–9

    Article  PubMed  Google Scholar 

  9. Niewald M, Seegenschmiedt MH, Micke O, Graber S (2008) Randomized multicenter trial on the effect of radiotherapy for plantar Fasciitis (painful heel spur) using very low doses–a study protocol. Radiat Oncol 3:27

    Article  PubMed Central  PubMed  Google Scholar 

  10. Ott OJ, Jeremias C, Gaipl US et al (2013) Radiotherapy for calcaneodynia. Results of a single center prospective randomized dose optimization trial. Strahlenther Onkol 189:329–334

    Article  CAS  PubMed  Google Scholar 

  11. Schafer U, Micke O, Heinrich Seegenschmiedt M, Mucke R (2010) Correspondence (letter to the editor): low-dose radiotherapy. Dtsch Arztebl Int 107:603–604

    PubMed Central  PubMed  Google Scholar 

  12. Rodel F, Keilholz L, Herrmann M et al (2007) Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol 83:357–366

    Article  CAS  PubMed  Google Scholar 

  13. Rodel F, Frey B, Gaipl U et al (2012) Modulation of inflammatory immune reactions by low-dose ionizing radiation: molecular mechanisms and clinical application. Curr Med Chem 19:1741–1750

    Article  CAS  PubMed  Google Scholar 

  14. von Pannewitz G (1970) Degenerative Erkrankungen. In: Diethelm I, Heuck F, Olsson O, Rauninger K, Strnad F, Vieten H, Zuppinger A (eds) Handbuch der medizinischen Radiologie, Vol 17. Springer Verlag Berlin, pp 73–107

  15. Seegenschmiedt MH, Keilholz L (1998) Epicondylopathia humeri (EPH) and peritendinitis humeroscapularis (PHS): evaluation of radiation therapy long-term results and literature review. Radiother Oncol 47:17–28

    Article  CAS  PubMed  Google Scholar 

  16. Muecke R, Micke O, Reichl B et al (2007) Demographic, clinical and treatment related predictors for event-free probability following low-dose radiotherapy for painful heel spurs—a retrospective multicenter study of 502 patients. Acta Oncol 46:239–246

    Article  PubMed  Google Scholar 

  17. Seegenschmiedt MH, Keilholz L, Stecken A et al (1996) [Radiotherapy of plantar heel spurs: indications, technique, clinical results at different dose concepts]. Strahlenther Onkol 172:376–383

    CAS  PubMed  Google Scholar 

  18. Niewald M, Seegenschmiedt MH, Micke O et al (2012) Randomized, multicenter trial on the effect of radiation therapy on plantar fasciitis (painful heel spur) comparing a standard dose with a very low dose: mature results after 12 months’ follow-up. Int J Radiat Oncol Biol Phys 84:e455–462

    Article  PubMed  Google Scholar 

  19. Trott KR, Kamprad F (2006) Estimation of cancer risks from radiotherapy of benign diseases. Strahlenther Onkol 182:431–436

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by the German Federal Ministry of Education and Research (GREWIS, 02NUK017G), and the European Commission (DoReMi, European Network of Excellence, contract number 249689).

Compliance with ethical guidelines

Conflict of interest

The authors declare that there are no actual or potential conflicts of interest in relation to this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Oliver J. Ott.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ott, O., Jeremias, C., Gaipl, U. et al. Radiotherapy for benign calcaneodynia. Strahlenther Onkol 190, 671–675 (2014). https://doi.org/10.1007/s00066-014-0618-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-014-0618-0

Keywords

Schlüsselwörter

Navigation